Bristol Myers Squibb reports strong Q2 results, but lowers earnings outlook due to charge from BioNTech partnership, as shares underperform the market.
Bristol Myers Squibb reports strong Q2 results, but lowers earnings outlook due to charge from BioNTech partnership, as shares underperform the market.